Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krista L Lanctôt

Showing results (1-10 of 333) with videos related to

Pageof 34
Sort By:
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 28, 2024
Commentary on Neuropsychiatric Symptom Profile in Alzheimer's Disease and their Relationship with Functional DeclineKrista L Lanctôt
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Commentary on "Health economics and the value of therapy in Alzheimer's disease." Cholinesterase inhibitors in Alzheimer's disease--evidence-based or evidence-biased?Krista L Lanctôt, Nathan Herrmann
Lancet (London, England)|October 24, 2021
Mirtazapine for agitation in dementia: moving forwardKrista L Lanctôt, Nathan Herrmann
CNS Drugs|February 9, 2005
Do atypical antipsychotics cause stroke?Nathan Herrmann, Krista L Lanctôt
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 21, 2007
Pharmacologic management of neuropsychiatric symptoms of Alzheimer diseaseNathan Herrmann, Krista L Lanctôt
Drug Safety|September 15, 2006
Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned?Nathan Herrmann, Krista L Lanctôt
Evidence-Based Mental Health|January 27, 2005
Review: donepezil improves cognitive and global function in people with mild to moderate Alzheimer's diseaseKrista L Lanctôt, Nathan Herrmann
Ageing Research Reviews|February 5, 2011
Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer's typeTanya Pinto, Krista L Lanctôt, Nathan Herrmann
The Journal of Clinical Psychiatry|August 26, 2016
Dr Mazereeuw and Colleagues ReplyGraham Mazereeuw, Krista L Lanctôt, Nathan Herrmann
The American Journal of Psychiatry|June 1, 2004
Atypical antipsychotics and risk of cerebrovascular accidentsNathan Herrmann, Muhammad Mamdani, Krista L Lanctôt
Pageof 34

Showing results (1-10 of 333) with videos related to

Sort By:
Pageof 34
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 28, 2024
Commentary on Neuropsychiatric Symptom Profile in Alzheimer's Disease and their Relationship with Functional DeclineKrista L Lanctôt
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Commentary on "Health economics and the value of therapy in Alzheimer's disease." Cholinesterase inhibitors in Alzheimer's disease--evidence-based or evidence-biased?Krista L Lanctôt, Nathan Herrmann
Lancet (London, England)|October 24, 2021
Mirtazapine for agitation in dementia: moving forwardKrista L Lanctôt, Nathan Herrmann
CNS Drugs|February 9, 2005
Do atypical antipsychotics cause stroke?Nathan Herrmann, Krista L Lanctôt
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 21, 2007
Pharmacologic management of neuropsychiatric symptoms of Alzheimer diseaseNathan Herrmann, Krista L Lanctôt
Drug Safety|September 15, 2006
Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned?Nathan Herrmann, Krista L Lanctôt
Evidence-Based Mental Health|January 27, 2005
Review: donepezil improves cognitive and global function in people with mild to moderate Alzheimer's diseaseKrista L Lanctôt, Nathan Herrmann
Ageing Research Reviews|February 5, 2011
Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer's typeTanya Pinto, Krista L Lanctôt, Nathan Herrmann
The Journal of Clinical Psychiatry|August 26, 2016
Dr Mazereeuw and Colleagues ReplyGraham Mazereeuw, Krista L Lanctôt, Nathan Herrmann
The American Journal of Psychiatry|June 1, 2004
Atypical antipsychotics and risk of cerebrovascular accidentsNathan Herrmann, Muhammad Mamdani, Krista L Lanctôt
Pageof 34